ID: h-6f6f920e83
Hypothesis

Sulfated glycans and metal-binding CSF proteins brace alpha-synuclein fibril polymorphs

Electrostatic bridging by glycans and low-abundance proteins preserves disease-relevant fibril architecture.
🧬 SNCA🩺 neurodegeneration🎯 Composite 49%💱 $0.51▲2.5%proposed
EvidencePending (0%)📖 5 cit🗣 1 debates 5 support 1 oppose
✓ All Quality Gates Passed
Mechanistic 0.52 (15%) Evidence 0.42 (15%) Novelty 0.62 (12%) Feasibility 0.59 (12%) Impact 0.45 (12%) Druggability 0.34 (10%) Safety 0.49 (8%) Competition 0.55 (6%) Data Avail. 0.47 (5%) Reproducible 0.44 (5%) KG Connect 0.35 (8%) 0.489 composite

🧪 Overview

Electrostatic bridging by glycans and low-abundance proteins preserves disease-relevant fibril architecture.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["SNCA Alpha-Synuclein<br/>Presynaptic Protein"]
    B["SNCA Misfolding<br/>Environmental Stress"]
    C["SNCA Oligomers<br/>Toxic Protofibrils"]
    D["Mitochondrial Pore<br/>Membrane Disruption"]
    E["Lewy Body Formation<br/>Cytoplasmic Inclusions"]
    F["Dopaminergic Neuron<br/>Dysfunction/Death"]
    G["Nigrostriatal Degeneration<br/>Motor Symptoms"]
    H["SNCA A53T/A30P/E46K<br/>Familial PD Mutations"]
    A --> B
    B --> C
    C --> D
    C --> E
    D --> F
    E --> F
    F --> G
    H -.->|"accelerates"| B
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style C fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style H fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8

⚖️ Evidence

⚖️ Evidence Matrix5 supports1 contradicts
Supports
Heparan sulfate proteoglycans in alpha-synuclein aggregation and Parkinsonism.
Acta Neuropathol2022PMID:35790300high
Supports
Glycosaminoglycans modulate alpha-synuclein fibrillation kinetics.
Acta Neuropathol2020PMID:32824376high
Supports
CSF glycosaminoglycans as biomarkers of synucleinopathy.
Acta Neuropathol2021PMID:34626424medium
Supports
Glycosaminoglycan-binding sites on alpha-synuclein govern aggregation and uptake.
Neurobiol Dis2022PMID:35962883high
Supports
Heparan sulfate modifications in dementia with Lewy bodies CSF.
Acta Neuropathol2023PMID:36995304medium
Contradicts
The mechanism remains too diffuse without isolation of a named molecular species.
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — SNCA

🧬 PDB 1XQ8 Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for SNCA from GTEx v10.

Cerebellar Hemisphere61.9 Frontal Cortex BA959.1 Anterior cingulate cortex BA2447.5 Cerebellum44.6 Cortex36.0 Spinal cord cervical c-125.7 Amygdala24.9 Nucleus accumbens basal ganglia21.6 Substantia nigra20.8 Hippocampus19.0 Hypothalamus18.5 Caudate basal ganglia13.5 Putamen basal ganglia12.4median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for SNCA →

No DepMap CRISPR Chronos data found for SNCA.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0145
Events (7d)
1
Price History
▲2.5%

💾 Resource Usage

LLM Tokens
1,502
$0.0045
Total Cost
$0.0045

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF we treat preformed alpha-synuclein fibrils with arylsulfatase A to enzymatically remove sulfated glycans, THEN the fibrils will exhibit reduced thermal stability (Tm decrease >5°C) and altered polyDecreased fibril thermal stability and loss of disease-relevant polymorph signatures— no observation —pending0.65
IF we supplement alpha-synuclein fibrillation reactions with physiological concentrations of metal-binding CSF proteins (ceruloplasmin 200 μg/mL, transferrin 300 μg/mL), THEN the resulting fibrils wilPreserved disease-associated fibril polymorphs with increased protease resistance— no observation —pending0.55
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF we treat preformed alpha-synuclein fibrils with arylsulfatase A to enzymatically remove sulfated glycans, THEN the fibrils will exhibit reduced thermal stability (Tm decrease >5°C) and altered polymorph distribution (decreased >40% in disease-associated fibril morphologies) within 2 hours of trea
Predicted outcome: Decreased fibril thermal stability and loss of disease-relevant polymorph signatures
Falsification: Fibrils retain wild-type thermal stability (Tm change <2°C) and maintain identical polymorph ratios, indicating sulfated glycans are not structural bracing elements
pendingconf 55%
IF we supplement alpha-synuclein fibrillation reactions with physiological concentrations of metal-binding CSF proteins (ceruloplasmin 200 μg/mL, transferrin 300 μg/mL), THEN the resulting fibrils will show preserved disease-associated polymorph architecture (matching >70% of untreated patient fibri
Predicted outcome: Preserved disease-associated fibril polymorphs with increased protease resistance
Falsification: Fibrils show no preference for disease-associated polymorphs (divergence >30% from reference library) and no change in protease susceptibility, indicating metal-binding proteins do not stabilize disea
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.